Cerebral organoids containing an AUTS2 missense variant model microcephaly

Brain. 2023 Jan 5;146(1):387-404. doi: 10.1093/brain/awac244.

Abstract

Variants in the AUTS2 gene are associated with a broad spectrum of neurological conditions characterized by intellectual disability, microcephaly, and congenital brain malformations. Here, we use a human cerebral organoid model to investigate the pathophysiology of a heterozygous de novo missense AUTS2 variant identified in a patient with multiple neurological impairments including primary microcephaly and profound intellectual disability. Proband cerebral organoids exhibit reduced growth, deficits in neural progenitor cell (NPC) proliferation and disrupted NPC polarity within ventricular zone-like regions compared to control cerebral organoids. We used CRISPR-Cas9-mediated gene editing to correct this variant and demonstrate rescue of impaired organoid growth and NPC proliferative deficits. Single-cell RNA sequencing revealed a marked reduction of G1/S transition gene expression and alterations in WNT-β-catenin signalling within proband NPCs, uncovering a novel role for AUTS2 in NPCs during human cortical development. Collectively, these results underscore the value of cerebral organoids to investigate molecular mechanisms underlying AUTS2 syndrome.

Keywords: AUTS2 syndrome; CRISPR-Cas9; cerebral organoids; microcephaly; neurodevelopmental disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autistic Disorder*
  • Cytoskeletal Proteins
  • Humans
  • Intellectual Disability* / genetics
  • Microcephaly* / genetics
  • Microcephaly* / metabolism
  • Neural Stem Cells*
  • Organoids / metabolism
  • Transcription Factors / metabolism

Substances

  • AUTS2 protein, human
  • Cytoskeletal Proteins
  • Transcription Factors